Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H25NO3.ClH |
| Molecular Weight | 303.825 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC([C@@H](O)[C@H](C)NC(C)(C)C)=C(OC)C=C1
InChI
InChIKey=URPAECSKKQLCII-LPJGFKLNSA-N
InChI=1S/C15H25NO3.ClH/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6;/h7-10,14,16-17H,1-6H3;1H/t10-,14-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C15H25NO3 |
| Molecular Weight | 267.3639 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Butoxamine is a selective antagonist of the beta2 adrenergic receptor. It was discovered in laboratories of Farbwerke Hoechst. Administration of 25-50 mg subcutaneously or 50-150 mg orally induced mescaline syndrome, disorders of consciousness and a psychotic episode with amnesia. At an oral dose of 5 mg, butoxamine inhibited metabolic changes induced by fasting and administration of catecholamines. Butoxamine was not developed further and is mainly used in biomedical research to study the functional role of beta2 receptors.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:46:45 GMT 2023
by
admin
on
Fri Dec 15 17:46:45 GMT 2023
|
| Record UNII |
2O68ZJ8BLQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
106565
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
227-169-5
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
DTXSID60897115
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
5696-15-1
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
6602683
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL289093
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
C64184
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY | |||
|
2O68ZJ8BLQ
Created by
admin on Fri Dec 15 17:46:45 GMT 2023 , Edited by admin on Fri Dec 15 17:46:45 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
